Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, single clinical study designed to evaluate its safety and
efficacy by using Microwave Ablation combine with Pembrolizumab in patients with Stage ⅢB-Ⅳ
Non-small Cell Lung.Cancer (NSCLC) who failed with first-line therapy.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University